Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Faeth Therapeutics, Inc. - Common Stock
(NQ:
FTH
)
26.99
+0.10 (+0.37%)
Delayed Quote
Updated: 10:18 AM EDT, Oct 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Faeth Therapeutics, Inc. - Common Stock
Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors
September 17, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026
September 08, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Faeth Therapeutics to Participate in Upcoming September Investor Conferences
September 01, 2026
From
Faeth Therapeutics
Via
Business Wire
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 28, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer
August 17, 2026
From
Faeth Therapeutics
Via
Business Wire
Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments
August 14, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 07, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Faeth Therapeutics to Present PK/PD Modeling That Informed PIKTOR Dose Selection in Ongoing FTH-PIK-201 Trial at Upcoming Scientific Conference
August 07, 2026
From
Faeth Therapeutics
Via
Business Wire
Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates
August 04, 2026
From
Faeth Therapeutics
Via
Business Wire
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 23, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 03, 2026
From
Faeth Therapeutics, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
